mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.35 |
0.06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.06 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.06 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.06 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.07 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.07 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.07 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |